We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Evolution 16 and MyLab Eight Take Center Stage for Esaote

By MedImaging International staff writers
Posted on 13 Mar 2016
Print article
At this year’s European Congress of Radiology (ECR), Esaote (Genoa, Italy), one of the world's leading producers of medical diagnostic systems, took the opportunity to launch their latest ultrasound solution, called MyLab Eight and their MRI upgrade, Evolution 16. Massimo Rosa, chief marketing officer, provided an overview of how the company was wetting the appetite of its European customers with demonstrations and explanations of why these products offered considerable advances over existing solutions.

Currently, economic restraints operating within healthcare in Europe mean that manufacturers need to be cognizant of the pressures that customers face when making purchasing decisions. “Furthermore, working in this environment, we are challenged by the growing life expectancy of the population and there is a clear need to make so-called pre-diagnoses and anticipate specific pathologies using innovative diagnostic tools.”

Against this conflicting background of pressures in healthcare systems in Europe and elsewhere, Esaote are launching their ultrasound platform called MyLab Eight. “This should fulfil the need for a primary diagnosis with high clinical efficacy capabilities. We also try to offer the customer, the highest value for money, understanding their constraints on expenditure yet also their need for a high standard of diagnostic capability.”

MyLab Eight incorporates the new MPowered Engine to optimize high-density and single-crystal transducers to enable images to be captured at greater depth in the body with unprecedented quality in difficult-to-scan patients. There is also a new wideview monitor that offers sharp diagnostic image clarity with enhanced spatial and contrast resolution.

“It offers a platform that can be expanded in the future with the addition of high technological features,” said Mr. Rosa.

Also at ECR 2016, Esaote launched their dedicated MRI, Evolution 16. “This is an answer to the needs of MRI management, increasing throughput, image quality and addressing challenging patients such as those at the higher end of the size spectrum,” explained Mr. Rosa.

This year the package introduces new coils designed to improve the comfort of large patients, as well as clinical tools such as the brain imaging option. “This is aimed at increasing the return on investment for our customers and to qualify spending money on this kind of system. Evolution 16 presents customers with the option to continue to get value out of their system for a longer period of time by upgrading with the minimum of investment in tools and software innovation,” concluded Mr. Rosa.

Essentially, Esaote’s Evolution 16 offers customers the possibility to extend the lifecycle of their machine. “Your machine is never acquired absolute, it can always be improved in different ways—coils, software and image quality.”

Related Links:

Esaote 


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Breast Imaging Workstation
SecurView
New
Computed Tomography (CT) Scanner
Aquilion Serve SP
New
Silver Member
Mobile X-Ray Barrier
Lead Acrylic Mobile X-Ray Barriers

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

General/Advanced Imaging

view channel
Image: The CIARTIC Move self-driving mobile C-arm has received FDA clearance (Photo courtesy of Siemens)

Self-Driving Mobile C-Arm Reduces Imaging Time during Surgery

Intraoperative imaging faces significant challenges due to staff shortages and the high demands placed on surgical teams in the operating room (OR). A common challenge during many OR procedures is the... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.